Endocrine Society GUIDELINES Bundle (free trial)

Acromegaly

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1140190

Contents of this Issue

Navigation

Page 5 of 7

Treatment Drugs Used for Acromegaly Drug (Brand) How Supplied Dosing Cabergoline a (Dostinex ® ) • Scored 0.5 mg tablets • 0.5-2.0 mg PO weekly, usually split twice a week Lanreotide b (Somatuline ® Depot) • 60, 90, and 120 mg sterile, single-use, pre-filled syringes • 60-120 mg deep subcut q4wks Octreotide b (Sandostatin ® ) • 50, 100 & 500 mcg/mL ampules • 50-500 mcg subcut tid (Sandostatin ® LAR) • 10, 20 & 30 mg/6 mL vials • 10-40 mg intraglutelly q4wks (monthly) Pegvisomant b (Somavert ® ) • 10, 15, 20, 25 & 30 mg powder for reconstitution • 40 mg subcut, then 10-30 mg daily based on serum IGF-1 a FDA-approved for hyperprolactinemic disorders b FDA-approved for acromegaly

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Acromegaly